Hsu Jason

Average Profitability
<0.0001%
Insider Buys Quantity
12
Insider Buys Sum
$813,688.06
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Hsu Jason

According to the SEC Form 4 filings, Hsu Jason, being in a position of

  1. director at Immix Biopharma, Inc.,
    оver the last 12 months, has bought 88300 shares for $338,059, and sold 0 shares,
    over all time since 2021-12-20, has bought 220300 shares for $813,688, and sold 0 shares.

The largest purchase of all time was on 2021-12-20 and amounted to 50000 shares of Immix Biopharma, Inc. for $250,000.

Biography of Hsu Jason

No biography is available at this moment.

2024-08-22PurchaseImmix Biopharma, Inc.
IMMX
director
8,100
0.0301%
$2.25$18,233-16.06%
2024-08-21PurchaseImmix Biopharma, Inc.
IMMX
director
15,000
0.0533%
$2.23$33,390-18.42%
2024-07-24PurchaseImmix Biopharma, Inc.
IMMX
director
6,000
0.0237%
$2.15$12,8770%
2024-07-18PurchaseImmix Biopharma, Inc.
IMMX
director
3,200
0.0123%
$2.07$6,639-0.49%
2023-12-11PurchaseImmix Biopharma, Inc.
IMMX
director
31,000
0.1596%
$4.67$144,894-48.91%
2023-12-08PurchaseImmix Biopharma, Inc.
IMMX
director
25,000
0.1278%
$4.88$122,025-51.75%
2023-09-15PurchaseImmix Biopharma, Inc.
IMMX
director
7,000
0.04%
$2.49$17,396+12.36%
2023-09-14PurchaseImmix Biopharma, Inc.
IMMX
director
10,000
0.0623%
$2.58$25,772+17.91%
2023-09-12PurchaseImmix Biopharma, Inc.
IMMX
director
30,000
0.1874%
$2.83$84,864+7.55%
2023-09-11PurchaseImmix Biopharma, Inc.
IMMX
director
25,000
0.1563%
$2.89$72,280+5.28%
2023-09-08PurchaseImmix Biopharma, Inc.
IMMX
director
10,000
0.0596%
$2.53$25,317+14.75%
2021-12-20PurchaseImmix Biopharma, Inc.
IMMX
director
50,000
2.0945%
$5.00$250,000-34.77%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.